The Rx for Growth: "Discover Drugs"

CEO Hank McKinnell talks about Pfizer's $100 million-a-week R&D budget, cancer drugs, and why probers are looking at rival Merck

Sometime over the next several weeks, Pfizer (PFE ) expects to complete the $55 billion acquisition of drugmaker Pharmacia (PHA ). Upon completion, Pfizer will be the third-largest corporation in the U.S., with a higher market cap than any company save for Microsoft (MSFT ) and General Electric (GE ).

To continue reading this article you must be a Bloomberg Professional Service Subscriber.